Your session is about to expire
← Back to Search
Beta-blocker
beta blocker discontinuation for Heart Failure (HFpEF-BB Trial)
N/A
Waitlist Available
Led By Kai Chen, MD,PhD
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and after 4 weeks of beta blocker discontinuation
Awards & highlights
HFpEF-BB Trial Summary
This trial will evaluate how well a heart medication works in 30 patients with heart failure.
Eligible Conditions
- Heart Failure
HFpEF-BB Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and after 4 weeks of beta blocker discontinuation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and after 4 weeks of beta blocker discontinuation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in KCCQ-23 score
Secondary outcome measures
6 minute walk test
Changes in biomarker
Changes in cardiac mechanics by echocardiography
HFpEF-BB Trial Design
1Treatment groups
Experimental Treatment
Group I: HFpEF patientsExperimental Treatment1 Intervention
HFpEF patient who are currently taking beta blockers
Find a Location
Who is running the clinical trial?
UConn HealthLead Sponsor
211 Previous Clinical Trials
60,591 Total Patients Enrolled
2 Trials studying Heart Failure
1,050 Patients Enrolled for Heart Failure
Kai Chen, MD,PhDPrincipal InvestigatorUConn Health
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger